Last reviewed · How we verify

NCT04597658

The Effectiveness of Body Weight Supported Treadmill Training in Stroke Patients

Completed NA Last updated 24 November 2023
What this trial tests

NA trial testing Bodyweight supported treadmill training (BWSTT) in Stroke in 30 participants. Completed in 15 May 2023.

Timeline
1 January 2021
Primary endpoint
1 July 2021
15 May 2023

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 January 2021
Primary completion1 July 2021
Estimated completion15 May 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 95, any sex, with Stroke or Cerebrovascular Accident. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aimed to evaluate the effects of exercise on body weight-supported treadmill in stroke patients on gait parameters, activity, body functions and quality of life, and to determine whether it has an effect on balance when applied in addition to conventional therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effectiveness of bodyweight-supported treadmill training in stroke patients: randomized controlled trial.
    Tarihci Cakmak E, Yaliman A, Torna G, Sen EI. · · 2024 · cited 5× · PMID 38363446 · DOI 10.1007/s10072-024-07385-z

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597658.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing